Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Recruiting 2Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Polycystic Ovary Syndrome 7Neoplasms 3Melanoma 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Ovarian Neoplasms 2Obesity 2Infertility 2Glioblastoma 2Endometrial Neoplasms 2Breast Neoplasms 2Adenocarcinoma Of Esophagus 2Uterine Cervical Neoplasms 1TP53 Y220C Mutation 1Sarcoma, Ewing 1Sarcoma 1Prostate Cancer Recurrent 1Progression-Free Survival 1Preleukemia 1Posterior Fossa Ependymal Tumor 1Osteosarcoma 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms by Site 1Metabolic Diseases 1Medulloblastoma 1Leukoplakia, Oral 1Leukemia, Myeloid, Acute 1Insulin Resistance 1Hyperandrogenism 1

Interventions

pembrolizumab 20Gemcitabine 18Cisplatin 14Magnetic Resonance Spectroscopy 13enfortumab vedotin 12Specimen Handling 10Cystectomy 10Docetaxel 8Mitomycin 7Standard of Care 6Cystoscopy 6Transurethral Resection of Bladder 5Radiotherapy 5Carboplatin 5durvalumab 4Practice Guidelines as Topic 4Nivolumab 4Radiation 3Multiparametric Magnetic Resonance Imaging 3Mitozytrex 3Fluorouracil 3tislelizumab 2dehydroftorafur 2cemiplimab 2avelumab 2alvimopan 2Therapeutics 2Surveys and Questionnaires 2Surgical Procedures, Operative 2Radiosurgery 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Urinary Bladder Neoplasms × Metformin × Clear all
NCT06215976 2024-08-20

The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer

Cairo University

Phase 4 Recruiting
78 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT03379909 2023-09-21

TROJAN

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2 Recruiting
49 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡